Novel Immunotherapy Treatment Combinations in Pediatric Solid Tumor Clinical Trials

Thomas Cash, MD, MSc
Pediatric Hematologist/Oncologist
Program Director of Solid Tumor
Aflac Cancer and Blood Disorders Center
Children’s Healthcare of Atlanta
Associate Professor of Pediatrics
Emory University School of Medicine
(speaking from AMBH CL.15132)

Beyond Radioligand Therapy: SSTR2-Targeted ADCs and Engineered γδ T Cells for Neuroendocrine Tumors

Christopher Doering, PhD
Professor of Pediatrics
Emory University School of Medicine
Aflac Cancer and Blood Disorders Center
Children’s Healthcare of Atlanta
(speaking from HSRB II N600)